Amin M Alousi

Amin M Alousi

UNVERIFIED PROFILE

Are you Amin M Alousi?   Register this Author

Register author
Amin M Alousi

Amin M Alousi

Publications by authors named "Amin M Alousi"

Are you Amin M Alousi?   Register this Author

60Publications

2200Reads

17Profile Views

Early Post-Transplant Minimal Residual Disease Assessment Improves Risk Stratification in Acute Myeloid Leukemia.

Biol Blood Marrow Transplant 2018 07 12;24(7):1514-1520. Epub 2018 Feb 12.

Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.02.003DOI Listing
July 2018

Impact of Fluid Overload as New Toxicity Category on Hematopoietic Stem Cell Transplantation Outcomes.

Biol Blood Marrow Transplant 2017 Dec 24;23(12):2166-2171. Epub 2017 Aug 24.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.08.021DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889108PMC
December 2017

Histologic Grade 1 Is Associated With Increased Nonrelapsed Mortality in Lower Gastrointestinal Graft Versus Host Disease.

Am J Surg Pathol 2017 Nov;41(11):1483-1490

Departments of *Stem Cell Transplantation and Cellular Therapy †Pathology ‡Gastroenterology, The University of Texas M.D. Anderson Cancer Center §Department of Pediatric Oncology, Baylor College of Medicine, Houston, TX ∥Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000914DOI Listing
November 2017

Feasibility of Lenalidomide Therapy for Persistent Chronic Lymphocytic Leukemia after Allogeneic Transplantation.

Biol Blood Marrow Transplant 2017 Aug 8;23(8):1405-1410. Epub 2017 May 8.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.04.027DOI Listing
August 2017

Age over Fifty-Five Years at Diagnosis Increases Risk of Second Malignancies after Autologous Transplantation for Patients with Hodgkin Lymphoma.

Biol Blood Marrow Transplant 2017 Jul 4;23(7):1059-1063. Epub 2017 Apr 4.

The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.03.030DOI Listing
July 2017

Intestinal Microbiota and Relapse After Hematopoietic-Cell Transplantation.

J Clin Oncol 2017 May 15;35(15):1650-1659. Epub 2017 Mar 15.

Jonathan U. Peled, Sean M. Devlin, Anna Staffas, Melissa Lumish, Raya Khanin, Eric R. Littmann, Lilan Ling, Satyajit Kosuri, Molly Maloy, John B. Slingerland, Katya F. Ahr, Kori A. Porosnicu Rodriguez, Yusuke Shono, Ann E. Slingerland, Melissa D. Docampo, Boglarka Gyurkocza, Doris M. Ponce, Juliet N. Barker, Miguel-Angel Perales, Sergio A. Giralt, Ying Taur, Eric G. Pamer, Robert R. Jenq, and Marcel R.M. van den Brink, Memorial Sloan Kettering Cancer Center; Jonathan U. Peled, Melissa D. Docampo, Boglarka Gyurkocza, Doris M. Ponce, Juliet N. Barker, Miguel-Angel Perales, Sergio A. Giralt, Ying Taur, Eric G. Pamer, Robert R. Jenq, and Marcel R.M. van den Brink, Weill Cornell Medical College; Melissa Lumish, New York University Langone Medical Center, New York, NY; Anthony D. Sung, Duke University Medical Center, Durham, NC; Daniela Weber, University Medical Center, Regensburg, Germany; and Amin M. Alousi, University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.3348DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455763PMC
May 2017

A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre study.

Lancet Haematol 2015 Jan 23;2(1):e21-9. Epub 2014 Dec 23.

Blood & Marrow Transplant Program, University of Michigan, Ann Arbor, MI, USA; The Tisch Cancer Institute, The Icahn School of Medicine at Mount Sinai Hospital, New York, NY, USA. Electronic address:

View Article

Download full-text PDF

Source
http://www.thelancet.com/pdfs/journals/lanhae/PIIS2352-3026(
Web Search
http://linkinghub.elsevier.com/retrieve/pii/S235230261400035
Publisher Site
http://dx.doi.org/10.1016/S2352-3026(14)00035-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4340092PMC
January 2015

Extracorporeal photopheresis in the treatment of graft-versus-host disease: evidence and opinion.

Ther Adv Hematol 2013 Oct;4(5):320-34

Department of Pharmacy Clinical Programs, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2040620713490316DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3766348PMC
October 2013

High-dose chemotherapy and autologous stem cell transplantation for nodular lymphocyte-predominant Hodgkin lymphoma.

Biol Blood Marrow Transplant 2013 Jun 16;19(6):991-4. Epub 2013 Mar 16.

Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2013.03.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4411554PMC
June 2013

Lymphocyte phenotype during therapy for acute graft-versus-host disease: a brief report from BMT-CTN 0302.

Biol Blood Marrow Transplant 2013 Mar 12;19(3):481-5. Epub 2012 Dec 12.

Hematologic Malignancies, the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21231, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2012.12.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3653300PMC
March 2013

Graft-versus-host disease: state of the science.

Biol Blood Marrow Transplant 2013 Jan 27;19(1 Suppl):S102-8. Epub 2012 Oct 27.

Dept of Stem Cell Transplant and Cellular Therapy, Univeristy of Texas, MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 423, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2012.10.028DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4116672PMC
January 2013

Graft-versus-host disease: part I. Pathogenesis and clinical manifestations of graft-versus-host disease.

J Am Acad Dermatol 2012 Apr;66(4):515.e1-18; quiz 533-4

Department of Dermatology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2011.11.960DOI Listing
April 2012

Graft-versus-host disease: part II. Management of cutaneous graft-versus-host disease.

J Am Acad Dermatol 2012 Apr;66(4):535.e1-16; quiz 551-2

Department of Dermatology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2011.11.961DOI Listing
April 2012

Role of ERCP in patients after hematopoietic stem cell transplantation.

Gastrointest Endosc 2011 Oct 29;74(4):817-24. Epub 2011 Jul 29.

Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.gie.2011.05.033DOI Listing
October 2011

Mesenchymal stem cells in ex vivo cord blood expansion.

Best Pract Res Clin Haematol 2011 Mar 23;24(1):83-92. Epub 2011 Feb 23.

Department of Stem Cell Transplantation and Cellular Therapy, University of Texas, M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15216926100013
Publisher Site
http://dx.doi.org/10.1016/j.beha.2010.11.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3805362PMC
March 2011

Graft-versus-host disease treatment: predictors of survival.

Biol Blood Marrow Transplant 2010 Dec 9;16(12):1693-9. Epub 2010 Jun 9.

Departments of Pediatrics and Internal Medicine, University of Michigan, 1500 E. Medical Center Drive, Ann Arbor, MI 48109-5941, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2010.05.019DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2955996PMC
December 2010

The role of B cell depleting therapy in graft versus host disease after allogeneic hematopoietic cell transplant.

Leuk Lymphoma 2010 Mar 8;51(3):376-89. Epub 2010 Feb 8.

Department of Stem Cell Transplant and Cellular Therapy, M. D. Anderson Cancer Center, University of Texas, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428190903586318DOI Listing
March 2010

A phase 1 trial of XK469: toxicity profile of a selective topoisomerase IIbeta inhibitor.

Invest New Drugs 2007 Apr 11;25(2):147-54. Epub 2006 Nov 11.

Karmanos Cancer Institute, Wayne State University School of Medicine, 4th Floor HWCRC, 4100 John R, Detroit, MI 48201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-006-9024-5DOI Listing
April 2007

Economic evaluation of aromatase inhibitors for the treatment of breast cancer.

Expert Rev Pharmacoecon Outcomes Res 2003 Dec;3(6):773-81

Barbara Ann Karmanos Cancer Institute, Wayne State University, 4th Floor, Hudson-Webber Cancer Research Center, 4100 John R, Detroit, MI 48201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737167.3.6.773DOI Listing
December 2003